Mesoblast Ltd (MESO) Price Targets From Analysts
Use the tables below to see what analysts covering Mesoblast Ltd think about its future price and what recommendations they have for investors and traders.
|Number of Analysts||Highest Target Price||Lowest Target Price||Average Target Price||Current Price||Upside Potential|
MESO Broker Recommendations Summary
|Average Broker Rating||Strong Buy||Buy||Hold||Sell||Strong Sell||Analysts Issuing Recs|
Use the points listed below to better contextualize what this analyst price target and recommendations data data means for investors.
- The variance in analysts' estimates of MESO is less than 3.48999999999999% of all US stocks.
- The percent of analysts bearish on the stock of MESO is less than 10.42% of Pharmaceutical Products stocks.
- The upside potential (average analyst target price relative to current price) of MESO is greater than 87.76% of stocks in the mid market cap category.
- MESO has a higher number of analysts covering the stock than 78.36% of Pharmaceutical Products stocks.
- Mesoblast Ltd's average analyst price target is greater than 25.52% of stocks in the mid market cap category.
- Mesoblast Ltd's percentage of analysts bullish on the stock is higher than 28.01% of Pharmaceutical Products stocks.
- The change in bullishness amongst analysts of MESO is lower than just about 100% of all US stocks.
What is the outlook for MESO? Use POWR Ratings for clearer insight into price direction.